http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020249223-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_843d2f69499d85d9d93247761b54cc0b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2035-00425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-5085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2035-0418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L9-543
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N35-1009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N35-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
filingDate 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd80f73af0b50e6ee4677fb8cbeb9ce1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b3cec232090e5fea0f04bbebbb6211b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35103b18e45d117138560433fed336ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d256caee32587f22d65736407e837ee1
publicationDate 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020249223-A1
titleOfInvention Componential Analyzer, Drug Efficacy Analyzer, and Analysis Method
abstract Application of the present invention enables quantification of fractions of candidate pharmaceutical compounds (a parent compound and its metabolites), one excreted to the basolateral (Basal/Basolateral)-side via transporters and by diffusion, one excreted to the lumen (Apical)-side, and one remained in the cells. This enables determination of the total amount of the administered candidate pharmaceutical compounds and the distribution ratio of the fractions. The kinetics of the administered candidate pharmaceutical compounds can be evaluated, thereby enabling in vitro screening of an enormous number of candidate pharmaceutical compounds for drug candidates exhibiting the efficacy. The object of the present invention is to provide an apparatus and method for understanding a total picture of pharmacokinetics in vitro by quantifying a fraction of basolateral (Basal/Basolateral) efflux, a fraction of lumen (Apical)-side excretion, and a fraction remaining in a cell of a drug which has been administered to the cell to determine the distribution ratio of each fraction.
priorityDate 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10684276-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737

Total number of triples: 40.